| 1 |
29748211 | Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL. | 2018 Aug |
1 |
| 2 |
23958920 | Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL. | 2014 Apr |
2 |
| 3 |
23334362 | Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. | 2013 Apr |
3 |
| 4 |
22282267 | Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. | 2012 Jun |
6 |
| 5 |
19965632 | Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. | 2010 Feb 4 |
2 |
| 6 |
20979663 | Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia. | 2010 Oct 28 |
1 |
| 7 |
9059068 | [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement]. | 1997 Feb |
1 |